Cardiac Biomarkers Market Size, Share & Trends Report

Cardiac Biomarkers Market Size, Share & Trends Analysis Report By Type (Troponin, CK-MB, Myoglobin, BNP and NT-proBNP, Others), By Application, By End Use, By Region, And Segment Forecasts, 2025 - 2030

Report ID: GVR-1-68038-083-5
Number of Report Pages: 100
Format: PDF

Historical Range: 2018 - 2023
Forecast Period: 2025 - 2030
Industry: Healthcare

Market Segmentation

Cardiac Biomarkers Type Outlook (Revenue in USD Million, 2018 - 2030)
- Troponin
- CK-MB
- Myoglobin
- BNP AND NT-PROBNP
- Others
Cardiac Biomarkers Application Outlook (Revenue in USD Million, 2018 - 2030)
- Acute Coronary Syndrome
- Myocardial Infarction
- Congestive Heart Failure
- Others
Cardiac Biomarkers End Use Outlook (Revenue in USD Million; 2018 - 2030)
- Laboratory Testing
- Point of Care Testing
Cardiac Biomarkers Regional Outlook (Revenue, USD Million, 2018 - 2030)
- North America
  - North America Type Outlook (Revenue in USD Million, 2018 - 2030)
    - Troponin
    - CK-MB
    - Myoglobin
    - BNP AND NT-PROBNP
    - Others
  - North America Application Outlook (Revenue in USD Million, 2018 - 2030)
    - Acute Coronary Syndrome
    - Myocardial Infarction
    - Congestive Heart Failure
    - Others
  - North America Application Outlook (Revenue in USD Million, 2018 - 2030)
    - Laboratory Testing
    - Point of Care Testing
  - U.S.
    - U.S. Type Outlook (Revenue in USD Million, 2018 - 2030)
      - Troponin
      - CK-MB
      - Myoglobin
      - BNP AND NT-PROBNP
      - Others
    - U.S. Application Outlook (Revenue in USD Million, 2018 - 2030)
      - Acute Coronary Syndrome
      - Myocardial Infarction
      - Congestive Heart Failure
      - Others
    - U.S. End Use Outlook (Revenue in USD Million, 2018 - 2030)
      - Laboratory Testing
      - Point of Care Testing
  - Canada
    - Canada Type Outlook (Revenue in USD Million, 2018 - 2030)
      - Troponin
      - CK-MB
      - Myoglobin
      - BNP AND NT-PROBNP
      - Others
    - Canada Application Outlook (Revenue in USD Million, 2018 - 2030)
      - Acute Coronary Syndrome
      - Myocardial Infarction
      - Congestive Heart Failure
      - Others
    - Canada End Use Outlook (Revenue in USD Million, 2018 - 2030)
      - Laboratory Testing
      - Point of Care Testing
  - Mexico
    - Mexico Type Outlook (Revenue in USD Million, 2018 - 2030)
      - Troponin
      - CK-MB
      - Myoglobin
      - BNP AND NT-PROBNP
      - Others
    - Mexico Application Outlook (Revenue in USD Million, 2018 - 2030)
      - Acute Coronary Syndrome
      - Myocardial Infarction
      - Congestive Heart Failure
      - Others
    - Mexico End Use Outlook (Revenue in USD Million, 2018 - 2030)
      - Laboratory Testing
      - Point of Care Testing
- Europe
  - Europe Type Outlook (Revenue in USD Million, 2018 - 2030)
    - Troponin
    - CK-MB
    - Myoglobin
    - BNP AND NT-PROBNP
    - Others
  - Europe Application Outlook (Revenue in USD Million, 2018 - 2030)
    - Acute Coronary Syndrome
    - Myocardial Infarction
    - Congestive Heart Failure
    - Others
  - Europe End Use Outlook (Revenue in USD Million, 2018 - 2030)
    - Laboratory Testing
    - Point of Care Testing
  - Germany
    - Germany Type Outlook (Revenue in USD Million, 2018 - 2030)
      - Troponin
      - CK-MB
      - Myoglobin
      - BNP AND NT-PROBNP
      - Others
    - Germany Application Outlook (Revenue in USD Million, 2018 - 2030)
      - Acute Coronary Syndrome
      - Myocardial Infarction
      - Congestive Heart Failure
      - Others
    - Germany End Use Outlook (Revenue in USD Million, 2018 - 2030)
      - Laboratory Testing
      - Point of Care Testing
  - UK
    - UK Type Outlook (Revenue in USD Million, 2018 - 2030)
      - Troponin
      - CK-MB
      - Myoglobin
      - BNP AND NT-PROBNP
      - Others
    - UK Application Outlook (Revenue in USD Million, 2018 - 2030)
      - Acute Coronary Syndrome
      - Myocardial Infarction
      - Congestive Heart Failure
      - Others
    - UK End Use Outlook (Revenue in USD Million, 2018 - 2030)
      - Laboratory Testing
      - Point of Care Testing
  - France
    - France Type Outlook (Revenue in USD Million, 2018 - 2030)
      - Troponin
      - CK-MB
      - Myoglobin
      - BNP AND NT-PROBNP
      - Others
    - France Application Outlook (Revenue in USD Million, 2018 - 2030)
      - Acute Coronary Syndrome
      - Myocardial Infarction
      - Congestive Heart Failure
      - Others
    - France End Use Outlook (Revenue in USD Million, 2018 - 2030)
      - Laboratory Testing
      - Point of Care Testing
  - Italy
    - Italy Type Outlook (Revenue in USD Million, 2018 - 2030)
      - Troponin
      - CK-MB
      - Myoglobin
      - BNP AND NT-PROBNP
      - Others
    - Italy Application Outlook (Revenue in USD Million, 2018 - 2030)
      - Acute Coronary Syndrome
      - Myocardial Infarction
      - Congestive Heart Failure
      - Others
    - Italy End Use Outlook (Revenue in USD Million, 2018 - 2030)
      - Laboratory Testing
      - Point of Care Testing
  - Spain
    - Spain Type Outlook (Revenue in USD Million, 2018 - 2030)
      - Troponin
      - CK-MB
      - Myoglobin
      - BNP AND NT-PROBNP
      - Others
    - Spain Application Outlook (Revenue in USD Million, 2018 - 2030)
      - Acute Coronary Syndrome
      - Myocardial Infarction
      - Congestive Heart Failure
      - Others
    - Spain End Use Outlook (Revenue in USD Million, 2018 - 2030)
      - Laboratory Testing
      - Point of Care Testing
  - Denmark
    - Denmark Type Outlook (Revenue in USD Million, 2018 - 2030)
      - Troponin
      - CK-MB
      - Myoglobin
      - BNP AND NT-PROBNP
      - Others
    - Denmark Application Outlook (Revenue in USD Million, 2018 - 2030)
      - Acute Coronary Syndrome
      - Myocardial Infarction
      - Congestive Heart Failure
      - Others
    - Denmark End Use Outlook (Revenue in USD Million, 2018 - 2030)
      - Laboratory Testing
      - Point of Care Testing
  - Sweden
    - Sweden Type Outlook (Revenue in USD Million, 2018 - 2030)
      - Troponin
      - CK-MB
      - Myoglobin
      - BNP AND NT-PROBNP
      - Others
    - Sweden Application Outlook (Revenue in USD Million, 2018 - 2030)
      - Acute Coronary Syndrome
      - Myocardial Infarction
      - Congestive Heart Failure
      - Others
    - Sweden End Use Outlook (Revenue in USD Million, 2018 - 2030)
      - Laboratory Testing
      - Point of Care Testing
  - Norway
    - Norway Type Outlook (Revenue in USD Million, 2018 - 2030)
      - Troponin
      - CK-MB
      - Myoglobin
      - BNP AND NT-PROBNP
      - Others
    - Norway Application Outlook (Revenue in USD Million, 2018 - 2030)
      - Acute Coronary Syndrome
      - Myocardial Infarction
      - Congestive Heart Failure
      - Others
    - Norway End Use Outlook (Revenue in USD Million, 2018 - 2030)
      - Laboratory Testing
      - Point of Care Testing
- Asia Pacific
  - Asia Pacific Type Outlook (Revenue in USD Million, 2018 - 2030)
    - Troponin
    - CK-MB
    - Myoglobin
    - BNP AND NT-PROBNP
    - Others
  - Asia Pacific Application Outlook (Revenue in USD Million, 2018 - 2030)
    - Acute Coronary Syndrome
    - Myocardial Infarction
    - Congestive Heart Failure
    - Others
  - Asia Pacific End Use Outlook (Revenue in USD Million, 2018 - 2030)
    - Laboratory Testing
    - Point of Care Testing
  - China
    - China Type Outlook (Revenue in USD Million, 2018 - 2030)
      - Troponin
      - CK-MB
      - Myoglobin
      - BNP AND NT-PROBNP
      - Others
    - China End Use Outlook (Revenue in USD Million, 2018 - 2030)
      - Acute Coronary Syndrome
      - Myocardial Infarction
      - Congestive Heart Failure
      - Others
    - China Application Outlook (Revenue in USD Million, 2018 - 2030)
      - Laboratory Testing
      - Point of Care Testing
  - Japan
    - Japan Type Outlook (Revenue in USD Million, 2018 - 2030)
      - Troponin
      - CK-MB
      - Myoglobin
      - BNP AND NT-PROBNP
      - Others
    - Japan Application Outlook (Revenue in USD Million, 2018 - 2030)
      - Acute Coronary Syndrome
      - Myocardial Infarction
      - Congestive Heart Failure
      - Others
    - Japan End Use Outlook (Revenue in USD Million, 2018 - 2030)
      - Laboratory Testing
      - Point of Care Testing
    - India Type Outlook (Revenue in USD Million, 2018 - 2030)
      - Troponin
      - CK-MB
      - Myoglobin
      - BNP AND NT-PROBNP
      - Others
    - India End Use Outlook (Revenue in USD Million, 2018 - 2030)
      - Acute Coronary Syndrome
      - Myocardial Infarction
      - Congestive Heart Failure
      - Others
    - India Application Outlook (Revenue in USD Million, 2018 - 2030)
      - Laboratory Testing
      - Point of Care Testing
  - Thailand
    - Thailand Type Outlook (Revenue in USD Million, 2018 - 2030)
      - Troponin
      - CK-MB
      - Myoglobin
      - BNP AND NT-PROBNP
      - Others
    - Thailand Application Outlook (Revenue in USD Million, 2018 - 2030)
      - Acute Coronary Syndrome
      - Myocardial Infarction
      - Congestive Heart Failure
      - Others
    - Thailand End Use Outlook (Revenue in USD Million, 2018 - 2030)
      - Laboratory Testing
      - Point of Care Testing
  - South Korea
    - South Korea Type Outlook (Revenue in USD Million, 2018 - 2030)
      - Troponin
      - CK-MB
      - Myoglobin
      - BNP AND NT-PROBNP
      - Others
    - South Korea Application Outlook (Revenue in USD Million, 2018 - 2030)
      - Acute Coronary Syndrome
      - Myocardial Infarction
      - Congestive Heart Failure
      - Others
    - South Korea End Use Outlook (Revenue in USD Million, 2018 - 2030)
      - Laboratory Testing
      - Point of Care Testing
  - Australia
    - Australia Type Outlook (Revenue in USD Million, 2018 - 2030)
      - Troponin
      - CK-MB
      - Myoglobin
      - BNP AND NT-PROBNP
      - Others
    - Australia Application Outlook (Revenue in USD Million, 2018 - 2030)
      - Acute Coronary Syndrome
      - Myocardial Infarction
      - Congestive Heart Failure
      - Others
    - Australia End Use Outlook (Revenue in USD Million, 2018 - 2030)
      - Laboratory Testing
      - Point of Care Testing
- Latin America
  - Latin America Type Outlook (Revenue in USD Million, 2018 - 2030)
    - Troponin
    - CK-MB
    - Myoglobin
    - BNP AND NT-PROBNP
    - Others
  - Latin America Application Outlook (Revenue in USD Million, 2018 - 2030)
    - Acute Coronary Syndrome
    - Myocardial Infarction
    - Congestive Heart Failure
    - Others
  - Latin America End Use Outlook (Revenue in USD Million, 2018 - 2030)
    - Laboratory Testing
    - Point of Care Testing
  - Brazil
    - Brazil Type Outlook (Revenue in USD Million, 2018 - 2030)
      - Troponin
      - CK-MB
      - Myoglobin
      - BNP AND NT-PROBNP
      - Others
    - Brazil Application Outlook (Revenue in USD Million, 2018 - 2030)
      - Acute Coronary Syndrome
      - Myocardial Infarction
      - Congestive Heart Failure
      - Others
    - Brazil End Use Outlook (Revenue in USD Million, 2018 - 2030)
      - Laboratory Testing
      - Point of Care Testing
  - Argentina
    - Argentina Type Outlook (Revenue in USD Million, 2018 - 2030)
      - Troponin
      - CK-MB
      - Myoglobin
      - BNP AND NT-PROBNP
      - Others
    - Argentina Application Outlook (Revenue in USD Million, 2018 - 2030)
      - Acute Coronary Syndrome
      - Myocardial Infarction
      - Congestive Heart Failure
      - Others
    - Argentina End Use Outlook (Revenue in USD Million, 2018 - 2030)
      - Laboratory Testing
      - Point of Care Testing
- Middle East and Africa
  - Middle East and Africa Type Outlook (Revenue in USD Million, 2018 - 2030)
    - Troponin
    - CK-MB
    - Myoglobin
    - BNP AND NT-PROBNP
    - Others
  - Middle East and Africa Application Outlook (Revenue in USD Million, 2018 - 2030)
    - Acute Coronary Syndrome
    - Myocardial Infarction
    - Congestive Heart Failure
    - Others
  - Middle East and Africa End Use Outlook (Revenue in USD Million, 2018 - 2030)
    - Laboratory Testing
    - Point of Care Testing
  - South Africa
    - South Africa Type Outlook (Revenue in USD Million, 2018 - 2030)
      - Troponin
      - CK-MB
      - Myoglobin
      - BNP AND NT-PROBNP
      - Others
    - South Africa Application Outlook (Revenue in USD Million, 2018 - 2030)
      - Acute Coronary Syndrome
      - Myocardial Infarction
      - Congestive Heart Failure
      - Others
    - South Africa End Use Outlook (Revenue in USD Million, 2018 - 2030)
      - Laboratory Testing
      - Point of Care Testing
  - Saudi Arabia
    - Saudi Arabia Type Outlook (Revenue in USD Million, 2018 - 2030)
      - Troponin
      - CK-MB
      - Myoglobin
      - BNP AND NT-PROBNP
      - Others
    - Saudi Arabia Application Outlook (Revenue in USD Million, 2018 - 2030)
      - Acute Coronary Syndrome
      - Myocardial Infarction
      - Congestive Heart Failure
      - Others
    - Saudi Arabia End Use Outlook (Revenue in USD Million, 2018 - 2030)
      - Laboratory Testing
      - Point of Care Testing
  - UAE
    - UAE Type Outlook (Revenue in USD Million, 2018 - 2030)
      - Troponin
      - CK-MB
      - Myoglobin
      - BNP AND NT-PROBNP
      - Others
    - UAE Application Outlook (Revenue in USD Million, 2018 - 2030)
      - Acute Coronary Syndrome
      - Myocardial Infarction
      - Congestive Heart Failure
      - Others
    - UAE End Use Outlook (Revenue in USD Million, 2018 - 2030)
      - Laboratory Testing
      - Point of Care Testing
  - Kuwait
    - Kuwait Type Outlook (Revenue in USD Million, 2018 - 2030)
      - Troponin
      - CK-MB
      - Myoglobin
      - BNP AND NT-PROBNP
      - Others
    - Kuwait Application Outlook (Revenue in USD Million, 2018 - 2030)
      - Acute Coronary Syndrome
      - Myocardial Infarction
      - Congestive Heart Failure
      - Others
    - Kuwait End Use Outlook (Revenue in USD Million, 2018 - 2030)
      - Laboratory Testing
      - Point of Care Testing

Report content

Qualitative Analysis

Industry overview
Industry trends
Market drivers and restraints
Market size
Growth prospects
Porter’s analysis
PESTEL analysis
Key market opportunities prioritized
Competitive landscape
- Company overview
- Financial performance
- Product benchmarking
- Latest strategic developments

Quantitative Analysis

Market size, estimates, and forecast from 2018 to 2030
Market estimates and forecast for product segments up to 2030
Regional market size and forecast for product segments up to 2030
Market estimates and forecast for application segments up to 2030
Regional market size and forecast for application segments up to 2030
Company financial performance

GET A FREE SAMPLE

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

Or view our licence options:

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

ESOMAR certified & member

ISO Certified

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.